The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects.
Open accessAbstract
Background & aims Nonalcoholic fatty liver disease is associated with insulin resistance and diabetes. The purpose of this study was to determine the relationship between intrahepatic triglyceride (IHTG) content and insulin action in liver (suppression of glucose production), skeletal muscle (stimulation of glucose uptake), and adipose tissue (suppression of lipolysis) in nondiabetic obese subjects.Methods A euglycemic-hyperinsulinemic clamp procedure and stable isotopically labeled tracer infusions were used to assess insulin action, and magnetic resonance spectroscopy was used to determine IHTG content, in 42 nondiabetic obese subjects (body mass index, 36 +/- 4 kg/m(2)) who had a wide range of IHTG content (1%-46%).Results Hepatic insulin sensitivity, assessed as a function of glucose production rate and plasma insulin concentration, was inversely correlated with IHTG content (r = -0.599; P < .001). The ability of insulin to suppress fatty acid release from adipose tissue and to stimulate glucose uptake by skeletal muscle were also inversely correlated with IHTG content (adipose tissue: r = -0.590, P < .001; skeletal muscle: r = -0.656, P < .001). Multivariate linear regression analyses found that IHTG content was the best predictor of insulin action in liver, skeletal muscle, and adipose tissue, independent of body mass index and percent body fat, and accounted for 34%, 42%, and 44% of the variability in these tissues, respectively (P < .001 for each model).Conclusions These results show that progressive increases in IHTG content are associated with progressive impairment of insulin action in liver, skeletal muscle, and adipose tissue in nondiabetic obese subjects. Therefore, nonalcoholic fatty liver disease should be considered part of a multiorgan system derangement in insulin sensitivity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, hepatic lipid accumulation is also a robust predictor of not only hepatic, but also muscle and adipose insulin sensitivity [better than intraabdominal fat, body mass index (BMI), or other obesity measures] (217, 218).”
From The role of mitochondria in the pathogenesis of type 2 diabetes (2010) · cites this paper as [218]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
The Michigan Alcoholism Screening Test: The Quest for a New Diagnostic Instrument
Selzer, M. L. (1971) · American Journal of Psychiatry · doi:10.1176/ajp.127.12.1653 · Cited by 3,431
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,728
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
Nonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,658
Cited by
Sorted by citations
Items 401–500 of 592
Heterogeneity in the effect of marked weight loss on metabolic function in women with obesity
Mittendorfer, B., Kayser, B. D., Yoshino, M., Yoshino, J., Watrous, J. D., Jain, M., Eagon, J. C., Patterson, B. W., & Klein, S. (2023) · JCI Insight · doi:10.1172/jci.insight.169541 · Cited by 10
Self-citationZhu, S., Wu, Z., Wang, W., Wei, L., & Zhou, H. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02216-y · Cited by 10
Choi, W. H., Um, M. Y., Ahn, J., Jung, C. H., & Ha, T. Y. (2014) · Journal of Medicinal Food · doi:10.1089/jmf.2013.3058 · Cited by 10
Cuthbertson, D. J., Irwin, A., Sprung, V. S., Jones, H., Pugh, C. J. A., Daousi, C., Adams, V. L., Bimson, W. E., Shojaee‐Moradie, F., Richardson, P., et al. (2014) · Clinical Science · doi:10.1042/cs20130404 · Cited by 10
Singal, P., Muniyappa, R., Chisholm, R., Hall, G., Chen, H., Quon, M. J., & Mather, K. J. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00603.2009 · Cited by 10
Moriguchi, H., Chung, R. T., Mihara, M., & Sato, C. (2010) · Hepatology · doi:10.1002/hep.23851 · Cited by 10
Sandby, K., Krarup, T., Chabanova, E., Geiker, N. R. W., & Magkos, F. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae572 · Cited by 11
LaPoint, A., Singer, J., Ferguson, D., Shew, T. M., Renkemeyer, M. K., Palacios, H. H., Field, R. L., Yerrathota, S., Kumari, R., Shankaran, M., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci169722 · Cited by 9
Self-citationvan den Burg, E. L., Schoonakker, M. P., van Peet, P. G., le Cessie, S., Numans, M. E., Pijl, H., & Lamb, H. J. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.02.017 · Cited by 9
Fatty Liver and Metabolic Syndrome in Nonabdominally Obese Taiwanese Adults
Chang, T.-Y., & Chen, J. (2011) · Asia Pacific Journal of Public Health · doi:10.1177/1010539511402191 · Cited by 9
Regular Exercise as a Secondary Practical Treatment for Nonalcoholic Fatty Liver Disease
Oh, S., Han, G., Kim, B., & Shoda, J. (2018) · Exercise Medicine · doi:10.26644/em.2018.004 · Cited by 9
Cree‐Green, M., Ravi, S., Carreau, A., Sewell, R. L., Baumgartner, A., Coe, G. V., Bergman, B. C., Scherzinger, A. L., Jensen, T., Pyle, L. L., et al. (2019) · Metabolism Open · doi:10.1016/j.metop.2019.100011 · Cited by 9
Lee, S., Song, D., Shin, S., Hong, N., & Rhee, Y. (2022) · Nutrition · doi:10.1016/j.nut.2022.111813 · Cited by 9
Hawley, N. L., Duckham, R. L., Carlson, J. C., Naseri, T. K., Reupena, M. S., Lameko, V., Pomer, A., Wetzel, A., Selu, M., Lupematisila, V., et al. (2022) · Obesity · doi:10.1002/oby.23559 · Cited by 9
Pathogenesis and research progress of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Shan, G.-Y., Wan, H., Zhang, Y., Cheng, J.-Y., Qiao, D.-R., Liu, Y.-Y., Shi, W., & Li, H. (2024) · World Journal of Hepatology · doi:10.4254/wjh.v16.i10.1142 · Cited by 9
The metabolic consequences of ‘yo-yo’ dieting are markedly influenced by genetic diversity
Thillainadesan, S., Lambert, A., Cooke, K. C., Stöckli, J., Yau, B., Masson, S. W. C., Howell, A., Potter, M., Fuller, O. K., Jiang, Y. L., et al. (2024) · International Journal of Obesity · doi:10.1038/s41366-024-01542-2 · Cited by 8
Graybeal, A. J., Brandner, C. F., Compton, A. T., Swafford, S. H., Aultman, R. S., Vallecillo‐Bustos, A., & Stavres, J. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.10.158 · Cited by 8
Wulan, S. N., Schrauwen‐Hinderling, V. B., Westerterp, K. R., & Plasqui, G. (2015) · Nutrition & Metabolism · doi:10.1186/s12986-015-0015-4 · Cited by 8
Exogenous estrogen protects mice from the consequences of obesity and alcohol
Holcomb, V. B., Hong, J., & Núñez, N. P. (2012) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31823cf6ee · Cited by 8
The Association between Dietary Lifestyles and Hepatocellular Injury in Japanese Workers
Iwata, T., Arai, K., Saito, N., & Murata, K. (2013) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.231.257 · Cited by 8
The Role of Metabolic Surgery in Non-alcoholic Steatohepatitis Improvement
Caravatto, P. P. D. P., & COHEN, R. V. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0681-y · Cited by 8
Zhang, T., Qi, Z., Wang, H., & Ding, S. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0840-3330 · Cited by 9
Cardiovascular Manifestations of Patients with Non-Alcoholic Fatty Liver Disease
Pădureanu, V., Forțofoiu, M.-C., Pîrșcoveanu, M., Pădureanu, R., Rădulescu, D., Donoiu, I., & Pîrșcoveanu, D. F. V. (2025) · Metabolites · doi:10.3390/metabo15030149 · Cited by 8
Elnegaard, J. J., Iena, F. M., Herold, J., & Lebeck, J. (2023) · The Journal of Physiology · doi:10.1113/jp284188 · Cited by 7
Goldberg, D. T., Meir, A. Y., Tsaban, G., Rinott, E., Kaplan, A., Zelicha, H., Klöting, N., Ceglarek, U., Iserman, B., Shelef, I., et al. (2024) · Hepatology · doi:10.1097/hep.0000000000000867 · Cited by 8
Accurate quantification of hepatic fat—is it important?
Adams, L. A. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.23 · Cited by 7
Subash‐Babu, P., Al‐Numair, N. S., Almuzaini, T., Athinarayanan, J., & Alshatwi, A. A. (2022) · Nanomaterials · doi:10.3390/nano12030368 · Cited by 7
The effect of acute and chronic exercise on hepatic lipid composition
Willis, S. A., Malaikah, S., Parry, S. A., Bawden, S., Ennequin, G., Sargeant, J. A., Yates, T. E., Webb, D. R., Davies, M. J., Stensel, D. J., et al. (2023) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.14310 · Cited by 7
Coffee Consumption is Associated with a Lower Incidence of Fatty Liver in Middle-aged Men
Funatsu, K., Yamashita, T., & Nakamura, H. (2011) · Eisei kagaku · doi:10.1248/jhs.57.406 · Cited by 7
Sato, T., Katabami, T., Furukawa, K., Narimatsu, H., Hashimoto, T., Nakajima, Y., Ohta, A., Sasaoka, T., & Tanaka, Y. (2011) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2011.09.001 · Cited by 7
Nonalcoholic Fatty Liver Disease
Argo, C. K., Henry, Z. H., & Caldwell, S. H. (2017) · Wiley eBooks · doi:10.1002/9781119251316.ch32 · Cited by 7
Nozaki, Y., Kobayashi, M., Wakasawa, H., Hoshino, S., Suwa, F., Ose, Y., Tagawa, R., & Higami, Y. (2023) · FEBS Open Bio · doi:10.1002/2211-5463.13610 · Cited by 6
Feline Diabetes Is Associated with Deficits in Markers of Insulin Signaling in Peripheral Tissues
Patra, S., McMillan, C. J., Snead, E. R., Warren, A. L., Cosford, K., & Chelikani, P. K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313195 · Cited by 7
Min, J., Park, H. S., Kim, Y. J., Yu, M. H., Jung, S. I., & Jeon, H. J. (2018) · Clinical Imaging · doi:10.1016/j.clinimag.2018.02.002 · Cited by 6
Shigiyama, F., Hiruma, S., Hisatake, S., Shiraga, N., Ikeda, T., Hirose, T., & Kumashiro, N. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0640-4 · Cited by 6
Methyltransferase SETD2 mediates hepatoprotection of berberine against steatosis
Li, D., Lu, S., Shen, T., Li, Y., & Chen, J. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-1753 · Cited by 6
Sopher, A. B., Gerken, A. T., Lee, E., Blaner, W. S., Deeds, S., Gallagher, D., Shungu, D. C., Mao, X., Hassoun, A. A., Mahon, D. J. M., et al. (2011) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2011.322 · Cited by 6
Mastromauro, C., Polidori, N., & Giannini, C. (2022) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000001138 · Cited by 6
Abruzzese, G. A., & Motta, A. B. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150928105959 · Cited by 6
Nonalcoholic Fatty Liver Disease
Caldwell, S. H., Argo, C. K., & Al‐Osaimi, A. M. S. (2011) · Wiley eBooks · doi:10.1002/9781119950509.ch32 · Cited by 6
Kim, J., Lee, S.-J., & Jee, Y. (2025) · BMC Sports Science Medicine and Rehabilitation · doi:10.1186/s13102-025-01156-9 · Cited by 5
Hu, H., Cao, C., Han, Y. Y., & He, Y. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.984241 · Cited by 5
Darcy, J., & Bartke, A. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-25650-0_11 · Cited by 5
Vittal, A., Shapses, M. A., Sharma, B., Sharma, D., Sun, Q., Sampson, M. L., Lee, W., Yakov, G. B., & Rotman, Y. (2020) · Hepatology Communications · doi:10.1002/hep4.1658 · Cited by 5
Hou, J., Liu, Y., Deng, Z., Sun, J., & Zhao, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1078652 · Cited by 5
Park, J., Roh, H., Park, J., Lee, Y., Lee, J., Jeong, D., Kim, S., Lee, M. K., Kim, S., & Kim, D.-H. (2023) · Aquaculture · doi:10.1016/j.aquaculture.2023.740296 · Cited by 5
Guiducci, L., Lionetti, V., Burchielli, S., Simi, C., Masi, S., Liistro, T., Pardini, S., Porciello, C., Cecco, P. D., Vettor, R., et al. (2011) · Endocrine Research · doi:10.3109/07435800.2010.534751 · Cited by 5
Fujibayashi, K., Gunji, T., Yokokawa, H., Naito, T., Sasabe, N., Okumura, M., Iijima, K., Shibuya, K., Hisaoka, T., & Fukuda, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149689 · Cited by 5
Feasibility of non-enhanced CT for assessing longitudinal changes in hepatic steatosis
Kim, M. G., Lee, S. S., Jun, M. J., Byun, J., Sung, Y. S., Shin, Y., & Lee, M.-G. (2019) · Medicine · doi:10.1097/md.0000000000015606 · Cited by 5
LaBranche, T. P., Kopec, A. K., Mantena, S. R., Hollingshead, B. D., Harrington, A. W., Stewart, Z. S., Zhan, Y., Hayes, K., Whiteley, L. O., Burdick, A. D., et al. (2020) · Toxicologic Pathology · doi:10.1177/0192623320968716 · Cited by 5
Not the enemy: superficial subcutaneous adipose tissue may bring protective benefits
Wu, S., & Chen, W. (2022) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.16237 · Cited by 5
Farabi, S. S., Smith, G. I., Schweitzer, G. G., Stein, R. I., & Klein, S. (2022) · International Journal of Obesity · doi:10.1038/s41366-022-01180-6 · Cited by 6
Self-citationClinical workup of fatty liver for the primary care provider
Jensen, T., Wieland, A. C., Cree‐Green, M., Nadeau, K. J., & Sullivan, S. A. (2018) · Postgraduate Medicine · doi:10.1080/00325481.2019.1546532 · Cited by 5
Hepatic miR‑215 target Rictor and modulation of hepatic insulin signalling in rats
Li, W., Jin-rong, X., & Lian, Y. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10031 · Cited by 5
Oka, R., Yagi, K., Nakanishi, C., Konno, T., Kawashiri, M., Hayashi, K., Nohara, A., Inazu, A., & Yamagishi, M. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.21790 · Cited by 5
Non-alcoholic Fatty Liver Disease and Cardiovascular Disease Risk
Targher, G. (2010) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-009-0070-3 · Cited by 5
Korean diet prevents obesity and ameliorates insulin resistance in mice fed a high-fat diet
Choi, W. H., Ahn, J., Jung, C. H., Seo, J., & Ha, T. Y. (2017) · Journal of Ethnic Foods · doi:10.1016/j.jef.2017.01.003 · Cited by 5
Jiang, S., Zhai, L., Shao, Y., Sun, F., & Liu, X. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1743899 · Cited by 5
Wang, Y., Zhang, Y., & Wang, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031051 · Cited by 4
Geniposide Mitigates Insulin Resistance and Hepatic Fibrosis via Insulin Signaling Pathway
Oh, S.-H., Lee, M.-S., & Lee, B.-C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26168079 · Cited by 4
Zhao, X., Jing, F., Ren, Y., Zhu, J., Jing, X., Lv, M., Huang, K., Guo, J., Li, J., Sun, X., et al. (2025) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2025-005339 · Cited by 5
Petersen, M. C., Smith, G. I., Farabi, S. S., Palacios, H. H., Shankaran, M., Hellerstein, M. K., Patterson, B. W., & Klein, S. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.07.020 · Cited by 5
Self-citationBhandari, C., & Agnihotr, N. (2022) · Nutrition Research · doi:10.1016/j.nutres.2022.07.003 · Cited by 4
Graybeal, A. J., Brandner, C. F., Wise, H. L., Henderson, A., Aultman, R. S., Vallecillo‐Bustos, A., Newsome, T. Q. A., Stanfield, D., & Stavres, J. (2024) · American Journal of Human Biology · doi:10.1002/ajhb.24141 · Cited by 4
Kugler, B. A., Maurer, A., Fu, X., Franczak, E., Ernst, N. J., Schwartze, K., Allen, J., Li, T., Crawford, P. A., Koch, L. G., et al. (2025) · Function · doi:10.1093/function/zqaf019 · Cited by 4
Hurjui, D. M., Niță, O., Graur, L. I., Popescu, D. Ş., Mihalache, L., Huţanaşu, C., & Graur, M. (2012) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/v10255-012-0037-x · Cited by 4
Guiu, B., Loffroy, R., Petit, J., Masson, D., Hillon, P., Cercueil, J., & Krause, D. (2009) · Journal de Radiologie · doi:10.1016/s0221-0363(09)73268-8 · Cited by 4
The evaluation and management of childhood type 2 diabetes mellitus
Scollan‐Koliopoulos, M., & Bleich, D. (2011) · Primary care diabetes · doi:10.1016/j.pcd.2011.04.002 · Cited by 4
Klein, S., Fabbrini, E., & Romijn, J. A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00036-5 · Cited by 4
Self-citationObesity: Classification and Diagnosis
Ferrulli, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-80267-7_6 · Cited by 5
Chen, Y., Zhang, S., Lu, Y., Li, L., Shi, Y., Lei, Y., Yang, X., & Wu, Z. (2022) · Medicinal Chemistry Research · doi:10.1007/s00044-022-02982-z · Cited by 4
Widmer, A., Mercante, M. G., & Silver, H. J. (2022) · Nutrients · doi:10.3390/nu14235106 · Cited by 4
Pálsdóttir, V., Olsson, B., Borén, J., Strandvik, B., & Gabrielsson, B. G. (2011) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2011.05.002 · Cited by 4
Lipid Metabolism And Control In Nonalcoholic Fatty Liver Disease
Charatcharoenwitthaya, P., & Lindor, K. D. (2009) · CRC Press eBooks · doi:10.1201/9781420085501.sec2 · Cited by 4
Gastrointestinal Complications and Management of Obesity
Black, D. D., & Gupta, S. K. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.08.012 · Cited by 4
Treating Fatty Liver for the Prevention of Cardiovascular Diseases†
Salomone, F., Galvano, F., & Volti, G. L. (2010) · Hepatology · doi:10.1002/hep.23741 · Cited by 4
LaPoint, A., Singer, J., Ferguson, D., Shew, T. M., Renkemeyer, M. K., Palacios, H. H., Field, R. L., Shankaran, M., Smith, G. I., Yoshino, J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.01.526676 · Cited by 4
Self-citationGeranylgeranyl Pyrophosphate Promotes Hepatic Lipid Accumulation by Prenylation of Perilipin4
Zhao, Y., Nie, H.-Y., Jiang, S., Zhao, M., Sun, P., Zhang, J., Wang, X.-C., Tang, Y., Zou, M., Yuan, X., et al. (2025) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2025.101546 · Cited by 3
London, A., Schaufuss, A., Považan, M., Dichman, M.-L., Merhout, J., Dirksen, C., Madsbad, S., Siebner, H. R., Lundsgaard, A., Fritzen, A. M., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf382 · Cited by 5
Bahadoran, Z., Mirmiran, P., Azizi, F., & Hosseinpanah, F. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.08.024 · Cited by 3
Masumi, M., Bahadoran, Z., Mirmiran, P., Khalili, D., Sarvghadi, F., & Azizi, F. (2024) · BMC Public Health · doi:10.1186/s12889-024-20680-w · Cited by 4
Huerta, N. G. M., Izquierdo, A. C., Hernández, J. A., Pérez, F. I. F., & Pérez-Martínez, M. (2015) · International Journal of Morphology · doi:10.4067/s0717-95022015000400030 · Cited by 3
Kim, Y.-H., Park, C. M., & Yoon, G.-A. (2016) · Journal of Nutrition and Health · doi:10.4163/jnh.2016.49.6.411 · Cited by 3
Pranger, I. G., van Raalte, D. H., Brands, M., Muskiet, M. H. A., Kema, I. P., Serlie, M. J. M., Diamant, M., Bakker, S. J. L., & Muskiet, F. A. J. (2018) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2018.03.009 · Cited by 3
Liu, B., Zheng, H., Liu, G., & Li, Z. (2021) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530321666210927153831 · Cited by 3
Song, J., Shi, X., Li, X., Liang, Q., Zeng, L., Li, G., Yan, Y., Xu, G., & Zheng, J. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.868602 · Cited by 4
Sciarrillo, C. M., Short, K. R., Keirns, B. H., Elliott, D. C., Clarke, S. L., Palle, S. K., & Emerson, S. R. (2023) · Pediatric Obesity · doi:10.1111/ijpo.13007 · Cited by 3
Obesity in India: Opportunities for clinical research
Dhurandhar, N. (2014) · Journal of Obesity and Metabolic Research · doi:10.4103/2347-9906.123874 · Cited by 3
Insulin resistance and “Lipotoxic Liver Diseases”
Ahammed, S. K. M., & Chowdhury, A. (2013) · Tropical Gastroenterology · doi:10.7869/tg.2012.82 · Cited by 3
Obesity and the Pathogenesis of Nonalcoholic Fatty Liver Disease
Fabbrini, E., & Magkos, F. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1203-2_9 · Cited by 3
Self-citationWorld Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease
Bloomgarden, Z. T. (2011) · Diabetes Care · doi:10.2337/dc11-1027 · Cited by 3
Metabolic Syndrome and Nonalcoholic Fatty Liver Disease
Gavril, O. I., Arhire, L. I., Mitu, O., Gavril, R. S., Maștaleru, A., Zota, M. I., Leon, M. M., Vasilcu, T. F., Mihalache, L., & Mitu, F. (2019) · Internal Medicine · doi:10.2478/inmed-2019-0052 · Cited by 3
Epidemiology of Nonalcoholic Fatty Liver Disease (NAFLD)
Aithal, G. P., Das, K., & Chowdhury, A. (2014) · Wiley eBooks · doi:10.1002/9781118727072.ch32 · Cited by 3
Correction: Effect of Pregnancy for Females Born Small on Later Life Metabolic Disease Risk
Tran, M., Gallo, L. A., Wadley, G. D., Jefferies, A. J., Moritz, K. M., & Wlodek, M. E. (2012) · PLoS ONE · doi:10.1371/annotation/0a0f4d8b-8ec3-4d62-8d0b-1917716beaa0 · Cited by 3
Optimizing nicotinic acid delivery for durable antilipolysis and improved metabolic control
Kroon, T. (2016) · Epsilon Open Archive (Sveriges lantbruksuniversitet biblioteket (Swedish University of Agricultural Sciences)) · Cited by 3
Nozaki, Y., Mizunoe, Y., Kobayashi, M., & Higami, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189172 · Cited by 2
Pathogenesis of Hepatic Steatosis and Fibrosis: Role of Leptin
Magkos, F., Fabbrini, E., & Klein, S. (2014) · Springer eBooks · doi:10.1007/978-3-319-09915-6_8 · Cited by 2
Self-citationMcCormick, C. D., Waters, H. N., Bezrukov, L., Taginya, R., Parikh, V. J., Onyekaba, G. I., Levine, J. A., Demidowich, A. P., Yanovski, J. A., Blank, P. S., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003751 · Cited by 3
Xie, Y., Li, S., Chen, R., He, R., Qian, L., Zou, J., Luo, Y., Zhang, Y., Ji, M., & Liu, Y. (2022) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2021.0090 · Cited by 2
Metadata
- Authors
- Korenblat, K. M., Fabbrini, E., Mohammed, B. S., & Klein, S.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Klein, Samuel
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2008-05
- Volume
- 134
- Issue
- 5
- Pages
- 1369-1375
- ISSN
- 0016-5085 (ISSN-L)
- PMC
- PMC2629391
- OpenAlex
- W2071867050
- Semantic Scholar
- 583ea7ff89ae3ebd20b01708b92228e15c0f7b02
- Cited by
- 592
- References
- 41
- Citations by year
- 2026: 14 · 2025: 20 · 2024: 31 · 2023: 40 · 2022: 36 · 2021: 32 · 2020: 21 · 2019: 27 · 2018: 32 · 2017: 32 · 2016: 32 · 2015: 32 · 2014: 36 · 2013: 38 · 2012: 44
- FWCI
- 30.68
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
- Funders
- National Institutes of Health (DK 37948, DK 56341, RR-00954, RR-00036)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- intrahepatic triglyceride, insulin resistance, non-alcoholic fatty liver disease, hepatic insulin sensitivity, skeletal muscle glucose uptake, adipose tissue lipolysis, glucose production, obesity
- MeSH terms
- Adipose Tissue, Adult, Energy Metabolism, Female, Humans, Insulin, Insulin Resistance, Liver, Magnetic Resonance Imaging, Male, Magnetic Resonance Spectroscopy, Obesity, Prognosis, Risk Factors, Triglycerides, Glucose Clamp Technique, Biomarkers, Absorptiometry, Photon, Body Mass Index, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review